Related references
Note: Only part of the references are listed.IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas
Adriana Olar et al.
ACTA NEUROPATHOLOGICA (2015)
Genetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastoma
Qun Liu et al.
ACTA NEUROPATHOLOGICA (2015)
IDH-Mutation Is a Weak Predictor of Long-Term Survival in Glioblastoma Patients
Aymeric Amelot et al.
PLOS ONE (2015)
Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation
Jinlong Shi et al.
TUMOR BIOLOGY (2015)
Mutant IDH1 is required for IDH1 mutated tumor cell growth
Genglin Jin et al.
Oncotarget (2015)
Characterizing invading glioma cells based on IDH1-R132H and Ki-67 immunofluorescence
Hemragul Sabit et al.
BRAIN TUMOR PATHOLOGY (2014)
Molecular analysis of diffuse intrinsic brainstem gliomas in adults
German Reyes-Botero et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation
Fumiharu Ohka et al.
TUMOR BIOLOGY (2014)
Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma
Patrick S. Tarpey et al.
NATURE GENETICS (2013)
Outcome and molecular characteristics of adolescent and young adult patients with newly diagnosed primary glioblastoma: a study of the Society of Austrian Neurooncology (SANO)
Annette Leibetseder et al.
NEURO-ONCOLOGY (2013)
D-2-hydroxyglutarate produced by mutant IDH1 perturbs collagen maturation and basement membrane function
Masato Sasaki et al.
GENES & DEVELOPMENT (2012)
IDH1 mutations inhibit multiple α-ketoglutarate-dependent dioxygenase activities in astroglioma
Ying Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
IDH1 R132H Decreases Proliferation of Glioma Cell Lines In Vitro and In Vivo
Linda B. C. Bralten et al.
ANNALS OF NEUROLOGY (2011)
Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome
Zachary J. Reitman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The prognostic IDH1 R132 mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma
Fonnet E. Bleeker et al.
ACTA NEUROPATHOLOGICA (2010)
Leukemic IDH1 and IDH2 Mutations Result in a Hypermethylation Phenotype, Disrupt TET2 Function, and Impair Hematopoietic Differentiation
Maria E. Figueroa et al.
CANCER CELL (2010)
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
Christian Hartmann et al.
ACTA NEUROPATHOLOGICA (2009)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Lenny Dang et al.
NATURE (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40
Emilie Vander Haar et al.
NATURE CELL BIOLOGY (2007)
PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration
Y Qian et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells
KA West et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
D Kim et al.
FASEB JOURNAL (2001)
Share Paper
